• Mashup Score: 2
    Grant will augment nurse-practitioner training in psychiatry - 2 year(s) ago

    Premera Blue Cross will invest $6.6 million to train advanced nurse practitioners in a psychiatry fellowship at the University of Washington. The fellowship will accept up to four ARNP fellows each year starting in 2023. Training will focus on inpatient, outpatient, telehealth consultation and integrated psychiatric care for mental health conditions, and include rotations at primary care clinics…

    Source: newsroom.uw.edu
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Cascadia
      Cascadia

      In order to integrate mental health into primary care we need more staff who are trained in the collaborative care model. $6 million Grant from insurance @premera will augment nurse-practitioner training in psychiatry @UWMedicine | #healthInnovation https://t.co/YQOjJNyxHE

  • Mashup Score: 3
    Clarivate names Highly Cited Researchers - 2 year(s) ago

    This year 37 UW School of Medicine faculty members and scientists affiliated with UW Medicine have been named to the Clarivate Highly Cited Researchers™ list. The list was released today, Nov. 15. Both quantitative and qualitative methods are used to identify individuals from across the globe who have demonstrated significant and broad influence in their chosen area of research. The preliminary…

    Source: newsroom.uw.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NicoleKuderer
      NicoleKuderer

      RT @gary_lyman: Clarivate names Highly Cited Researchers https://t.co/Z3a6ZnVBDR Thanks to all the amazing mentees and colleagues who make…

  • Mashup Score: 2
    Clarivate names Highly Cited Researchers - 2 year(s) ago

    This year 37 UW School of Medicine faculty members and scientists affiliated with UW Medicine have been named to the Clarivate Highly Cited Researchers™ list. The list was released today, Nov. 15. Both quantitative and qualitative methods are used to identify individuals from across the globe who have demonstrated significant and broad influence in their chosen area of research. The preliminary…

    Source: newsroom.uw.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of gary_lyman
      gary_lyman

      Clarivate names Highly Cited Researchers https://t.co/Z3a6ZnVBDR Thanks to all the amazing mentees and colleagues who make this happen for the 5th consecutive year @NicoleKuderer @PavlosMsaouel @aakonc @fredhutch

  • Mashup Score: 3
    To improve a promising cancer drug, cut it in half - 2 year(s) ago

    A new study shows that when an experimental cancer medication is split in half, the molecule becomes safer and more effective. Scientists at the University of Washington School of Medicine were looking for ways to improve a promising cancer drug called Neo-2/15. This protein was created to mimic the function of Interleukin-2, or IL-2, which is a natural molecule that can amp up immune cells to…

    Source: newsroom.uw.edu
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NatureBiotech
      NatureBiotech

      @UWBiochemistry @UWproteindesign @UWBioE @DanaFarber @MassGeneralNews @harvardmed @HopkinsEngineer @fredhutch @HHMINEWS @SpanglerLab To improve a promising cancer drug, cut it in half #NBTintheNews via @uwmnewsroom https://t.co/q3OvuLyPDR

  • Mashup Score: 10
    Gene-edited malaria vaccine warrants more study - 2 year(s) ago

    Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration. The study’s proof-of-concept results are reported today in Science Translational Medicine. The research was headed by investigators at the University of Washington School of Medicine, Seattle Children’s Research Institute, and Kaiser…

    Source: newsroom.uw.edu
    Categories: Healthcare Professionals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NIHDirector
      NIHDirector

      Healthy volunteers in a Phase 2 clinical trial responded well to a new vaccine strategy for #malaria. Participants showed signs of protection against the virus for at least 1 month & the vaccine was safe & well-tolerated. https://t.co/KhMTEoPgbA @NIAIDnews #NIH

  • Mashup Score: 0
    Study addresses living well after ovarian cancer - 2 year(s) ago

    Once you are diagnosed as in remission from ovarian cancer, can you heave a big sigh of gratitude and move on with your life? Perhaps not, says a UW Medicine gynecologic oncologist. For the past two years, Dr. Kathryn Pennington has been an investigator on the Living Well Study, which examines interventions that can help with successful recovery and life after ovarian cancer. Pennington will…

    Source: newsroom.uw.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
  • Mashup Score: 3
    Study addresses living well after ovarian cancer - 3 year(s) ago

    Once you are diagnosed as in remission from ovarian cancer, can you heave a big sigh of gratitude and move on with your life? Perhaps not, says a UW Medicine gynecologic oncologist. For the past two years, Dr. Kathryn Pennington has been an investigator on the Living Well Study, which examines interventions that can help with successful recovery and life after ovarian cancer. Pennington will…

    Source: newsroom.uw.edu
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SwisherLiz
      SwisherLiz

      Such a a great study for ovarian cancer survivors! Concrete ways at home to improve survivorship and quality of life, while participating in research to help others. Way to go @KPenningtonMD! @MNOvarianCancer @ocrahope @UWashOBGYN https://t.co/KbNfots9p6

Load More